• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Inhibikase Therapeutics

parachute chutes
Biotech

Private equity firms take over bluebird's nest—Chutes & Ladders

Private equity firms take over bluebird’s nest. Novartis vet vaults to FoRx. Indivior IDs next CEO.
Darren Incorvaia , Zoey Becker Feb 28, 2025 8:30am
Italy parachute alps mountain paraglide

NIH leaders join health agency exodus—Chutes & Ladders

Feb 21, 2025 8:30am
visual of neurons under Parkinsons disease

Inhibikase hits pause on Parkinson's program over efficacy

Jan 30, 2025 4:30am
Photo of a broken chain next to a small pair of plyers

Inhibikase clears another clinical hold, preps new phase 2 trial

Mar 8, 2023 10:18am
photo of a green light on a stoplight

Inhibikase, FDA agree on terms to lift Parkinson's drug hold

Jan 25, 2023 11:24am
visual of neurons under Parkinsons disease

Inhibikase stock sinks on FDA clinical hold of Parkinson's drug

Nov 7, 2022 9:25am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings